GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Ocean Biomedical OCEA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Net income

−$3.3m

FY2019FY2024

Free cash flow

−$4.2m

FY2019FY2024

Shareholders' equity

−$97.6m

FY2019FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019
Research and development$26,000$709,000$8.4m$33.9m$49,000$35,000
Operating income−$3.8m−$10.2m−$2.5m−$62.3m−$1.7m−$232,000
Net income−$3.3m−$114.5m$565,470−$62.3m−$1.7m−$232,000
Diluted earnings per share-0.09-4.190.04-4.72-0.08-0.01

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019
Total assets$902,000$5.5m$110.9m$108.7m$386,000—
Cash and short-term investments$224,000$4,000$328,305$1.1m——
Total liabilities$98.5m$96.3m$6.6m$3.4m$2.3m$232,000
Debt$16.3m$12.1m$2.1m———
Shareholders' equity−$97.6m−$90.8m$104.3m$105.3m−$1.9m−$232,000
Shares outstanding35m27m13m13m20m28m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−$4.2m−$9.4m−$747,297−$1.1m−$64,000−$64,000
Capital spending——−$3———
Free cash flow−$4.2m−$9.4m−$747,300−$1.1m−$64,000−$64,000

Latest quarters

By quarter end

Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023
Operating income−$958,000−$1.8m−$768,000−$682,000−$595,000$660,000−$2.7m−$2.7m
Net income−$8.2m$283,000−$5.5m−$17.2m$13.0m−$16.9m−$14.1m−$13.0m
Diluted earnings per share-0.300.01-0.16-0.490.37-0.62-0.52-0.48
Cash from operations—−$2.0m————−$1.0m−$4.0m
Total assets$1.6m$902,000$1.1m$1.9m$2.9m$5.5m$1.0m$20.9m
Cash and short-term investments$777,000—$240,000$4,000$19,000$4,000$31,000$1.2m
Debt$9.3m—$12.8m$11.0m$9.9m$12.1m$12.1m$11.9m
Shareholders' equity−$92.4m−$97.6m−$98.1m−$92.7m−$75.8m−$90.8m−$75.2m−$8.4m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-60.7%74.9%—
Net income-62.4%70.1%—

Share price return

Finished calendar years

202520242023
Return-51%-1%-90%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1-to-1 reverse split · 15 Feb 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.